Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

Robert F. Kennedy Jr., told senators Thursday he would support the development and distribution of avian flu vaccines for ...

The award will also support the expansion of clinical studies for up to five additional subtypes of pandemic influenza, Moderna said on Friday. “Avian flu variants have proven to be particularly ...

As bird flu continues to threaten animals and public health, the U.S. government has stepped up its response. Experts says it ...